Abstract
After N-acetylglucosaminyltransferase V (GnT-V) activity was down-regulated by the transfection of its antisense cDNA(GnTV-AS), apoptosis of H7721 cells was appeared and the apoptosis induced by 80μM all-transretinoic acid (ATRA) was facilitated, while ATRA itself could not induce apparent apoptosis in mock cells transfected with the vector. In the study of the molecular mechanism of this phenomenon, it was found that GnTV-AS reduced the expressions of anti-apoptotic proteins, such as phosphorylated protein kinase B and phosphorylated Bad as well as Bcl-2 and Bcl-X L, and elevated those of pro-apoptotic proteins, including Bax, full length caspase-3 and its activated fragments as well as anti-oncoprotein p53. In the contrast, ATRA up regulated the expressions of Bax and activated caspase-3 fragments only. After the GnTV-AS transfected cells were treated with ATRA, phosphorylated PKB and Bad were further decreased, while Bax and activated caspase-3 fragment were further increased, leading to the enhanced apoptosis in flow-cytometry analysis when compared with GnTV-AS cells not treated with ATRA. It was speculated that the decreased phospho-Bad resulted from the reduced phospho-PKB and the up regulation of p53 caused the elevated activity of Bax. The increased active caspase-3 was the consequence of the elevated Bax/ Bcl-2(Bcl-X L) activity ratio in the cells.
Similar content being viewed by others
Abbreviations
- GnT-V:
-
N-acetylglucosaminyltransferase V
- GnTV-AS:
-
antisense cDNA of N-acetylglucosaminyltransferase V
- GlcNAc:
-
N-acetylglucosamine; Man, mannose;ATRA, all-trans retinoic acid
- HPLC:
-
high performance liquid chromatography
- FITC:
-
fluorescein isothiocyanate; PI, propidium iodide
- FCM:
-
flow-cytometry; FACS, Fluorescence-activated cell spectra
- I≖sB:
-
inhibitor of nuclear factor kappa B (NFκB)
- HRP:
-
horseradish peroxidase; ECL, enhanced chemiluminescence
- PKB(Akt):
-
protein kinase
- B; EGTA:
-
ethylene glycol-bis (â-aminoethyl ester) N,N,N′,N′-tetraacetic acid
References
Brockhausen I, Narasimhan S, Schachter H: The biosynthesis of highly branched N-glycans. studies on the sequential pathway and functional role of N-acetylglycosaminyltransferase I, II, III, IV, V and VI. Biochimie 70: 1521–1533, 1988
Taniguchi N, Miyoshi E, Ko JH, Ikeda Y, Ihara Y: Implication of N-acetylglucosaminyl-transferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta 1455: 287–300, 1999
Yao M, Zhou DP, Jiang SM, Wang XH, Tang ZY, Gu JX: Elevated activity of N-acetyl- glucosaminyltransferase V in human hepatocellular carcinoma. J Cancer Res Clin Oncol 124: 27–30, 1998
Nan BC, Shao DM, Chen HL, Huang Y, Gu JX, Zhang YB, Wu ZG: Alteration of N-acetyl- glucosaminyltransferases in pancreatic carcinoma. Glycoconj J 15: 1033–1037, 1998
Dennis JW, Granovsky M, Warren CE: Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1473: 21–24, 1999
Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW: β.1,6 branched oligosaccharides as a marker of tumor progression in human breast and neoplasia. Cancer Res. 51: 718–723, 1991
Guo HB, Zhang QS, Chen HL: Effects of H-ras and v-sis over-expression on N-acetylgluco- saminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells. J Cancer Res Clin Oncol 126: 263–270, 2000
Guo HB, Liu F, Zhao JH, Chen HL: Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells. J Cell Biochem 79: 370–385, 2000
Guo HB, Zhang Y, Chen HL: Relationship between metastasis-associated phenotypes and N-glycan structure of surface glycoproteins in human hepatocarcinoma cells. J Cancer Res Clin Oncol 127: 231–236, 2001
Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 281: 1305–1308, 1998
Kroemer G: Mitochondrial control of apoptosis: an introduction. Biochem BiophysResCommun 304: 433–435, 2003
Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383–424, 1999
Budihardjio I, Oliver H, Lutter M, Luo X, Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269–290, 1999
Adams JM, Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61–66, 2001
Tsujimoto Y, Shimizu S: Bcl-2 family: life-or-death switch. FEBS Lett 466: 6–10, 2000
Scorrano L, Korsmeyer SJ: Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304: 4437–444, 2003
Antonsson B, Martinou JC: The Bcl-2 protein family. Exp Cell Res 256: 50–57, 2000
Yin XM, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and hetrodimerization with Bax. Nature 369: 321–323, 1994
Datta, SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. Gene & Development 13: 2905–2927, 1999
Kennedy SG., Kandel ES, Cross TK, Hay N: Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol. 19: 5800–5810, 1999
Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. Phosphoinositide-3OH kinase-dependent regulation of glycogen synthetase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211–11216, 1998
Guo HB, Liu F, Chen HL: Increased susceptibility to apoptosis of human hepatocarcinoma cells transfected with antisense N-acetylglucosaminyltransferase V cDNA. Biochem Biophys Res Commun 264: 509–517, 1999
Guo Jian-ming, Zhang Xia-ying, Chen Hui-li, Wang Guo-ming, Zhang Yong-kang: Structural alterations of sugar chains in urine fibronectin from bladder cancer patients and its enzymatic mechanism. J Cancer Res Clin Oncol 127: 512–519, 2001
Adrain C, Creagh EM. Martin SJ: Defying death: showing Bcl-2 the way home. Nature Cell Biology 5: 9–11, 2003
Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-kappa B is the answer – role of Rel/NF-kappa B in the regulation of apoptosis. Oncogene 22: 8961–8982, 2003
Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010–1014, 2004
Gaur U, Aggarwal BR: Regulation of proliferation, survival and apoptosis by members of the TNF family, Biochem Parmacol 66: 1403–1408, 2003
Guo P, Wang QY, Guo HB, Shen ZH, Chen HL. N-acetylglucosaminyl-transferase-V modifies the signaling pathway of epidermal growth factor receptor. Cell Mol Life Sci. 61: 1975–1804, 2004
Guo Peng, Zhang Ying, Zhao Jia-hong, Wang Li-ying, Guo Hua-bei, Zhang Xia-Ying, Chen Hui-Li: Regulation on the expression and N-glycosylation of integrin by N-acetyl- glucosaminyltransferase V. Biochem Biophy Res Commun 310: 619–626, 2003
Guo Peng, Zhang Ying, Shen Zong-hou, Zhang Xia-ying: Chen Hui-li Effect of N-acetylglucosaminyltransferase V on the expressions of other glycosyltransferases. FEBS lett 562: 93–96, 200.
Author information
Authors and Affiliations
Corresponding author
Additional information
These two persons contributed to this article equally.
Rights and permissions
About this article
Cite this article
Guo, P., Chen, Hj., Wang, Qy. et al. Down regulation of N-acetylglucosaminyltransferase V facilitates all-transretinoic acid to induce apoptosis of human hepatocarcinoma cells. Mol Cell Biochem 284, 103–110 (2006). https://doi.org/10.1007/s11010-005-9022-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-9022-5